Working together to address addiction, serious mental illness and cancer



We are actively researching new immuno-oncology agents for cancer patients in tumor types where we see significant need and opportunity for new treatment options.
We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with schizophrenia and bipolar I disorder.
We have been at the forefront of addiction medicine for more than a decade, seeking to help people living with alcohol dependence and opioid dependence.
We strive to have a positive impact on our employees, members of our communities, our local environment and society at large. We support research, education and patient advocacy programs with high potential to benefit people affected by serious mental illness, addiction or cancer. We also give back...
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that fosters equality and compassion, where we strive to make sure that all voices are respected and valued.




Subscribe to Alkermes